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Objective: The long-term performance of cell-seeded matrix-based cartilage constructs depends on (1)
the development of sufﬁcient biomechanical properties, and (2) lateral integrationwith host tissues, both
of which require cartilage-speciﬁc matrix deposition within the scaffold. In this study, we have examined
the potential of tissue-engineered cartilage analogs developed using different cell types, i.e., mesen-
chymal stem cells (MSCs) vs chondrocytes and de-differentiated chondrocytes, in an established
“construct in cartilage ring” model.
Design: Cell-laden constructs of differentiated chondrocytes, de-differentiated chondrocytes after two,
ﬁve or eight population doublings, and MSCs were either implanted into a native cartilage ring imme-
diately after fabrication (immature group) or pre-treated for 21 days in a transforming growth factor-b3
(TGF-b3) containing medium prior to implantation. After additional culture for 28 days in a serum-free,
chemically deﬁned medium, the extent of lateral integration, and biochemical and biomechanical
characteristics of the implants as hybrid constructs were assessed.
Results: The quality of integration, the amount of accumulated cartilage-speciﬁc matrix components and
associated biomechanical properties were found to be highest when using differentiated chondrocytes.
De-differentiation of chondrocytes negatively impacted the properties of the implants, as even two
population doublings of the chondrocytes in culture signiﬁcantly lowered cartilage repair capacity. In
contrast, MSCs showed chondrogenic differentiation with TGF-b3 pre-treatment and superior integra-
tional behavior.
Conclusions: Chondrocyte expansion and de-differentiation impaired the cell response, resulting in
inferior cartilage repair in vitro. With TGF-b3 pre-treatment, MSCs were able to undergo sustained
chondrogenic differentiation and exhibited superior matrix deposition and integration compared to de-
differentiated chondrocytes.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
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achieved by any of these methods5,6. In addition to the fact that the
newly synthesized tissue largely consists of ﬁbrocartilage and ex-
hibits inferior mechanical properties7e9, the utilization of autolo-
gous chondrocytes entails additional disadvantages. Speciﬁcally,
limited availability of healthy chondrocytes and chondrocyte de-
differentiation upon culture expansion10,11 underscore the need
for an alternative cell source.
By virtue of their easy availability from various tissues12e15,
extensive self-renewal capacity and chondrogenic differentiation
potential, adult mesenchymal stem cells (MSCs) have been
considered a promising cell source3,16e19. A large number of reports
over the last decade have demonstrated the chondrogenic differ-
entiation of MSCs employing various biomaterials, and the pro-
chondrogenic, anabolic effects of growth factors, such as trans-
forming growth factor-b3 (TGF-b3), strongly suggesting the appli-
cability of MSCs for cartilage repair3,18,20e22.
In principle, successful matrix-based cartilage repair in vivo re-
lies on sustained cartilage-speciﬁc matrix deposition within the
cell-laden scaffold, the development of sufﬁcient mechanical
properties and, in particular, integration of the developing neo-
cartilage into the surrounding native cartilage18,23,24. Inferior
interface stability impairs mechanical integrity of the restored joint
surface, and may lead to pathological load distribution in the joint
and long-term failure of the cartilage repair procedure. The inter-
action of the opposing tissues at the interface site, which is
dependent on appropriate cellular activity and matrix deposition,
determines the fate of a functional junction1,2,25.
In cartilage tissue engineering, it has been shown that matrix
deposition and mechanical properties of the engineered constructs
depend signiﬁcantly on the utilized cell type, cell-to-volume ratio,
and culture conditions26e28. Unfortunately, expansion of chon-
drocytes in monolayer culture is accompanied by their de-
differentiation and loss of cartilage-speciﬁc gene expression10,11.
In practice, de-differentiated chondrocytes are often processed and
used for re-differentiation and subsequent deposition within a
matrix to simulate a controlled pro-chondrogenic, three-dimen-
sional environment prior to implantation29,30. In this manner,
tissue-engineered cartilage analogs matured ex vivo have been
shown to show enhanced cartilage repair in vivo, with increased
amount of newly synthesized hyaline cartilage30e32.
Compared to in vivo animal cartilage repair models that are
time-consuming, expensive, and more difﬁcult to control, in vitro
cartilage repair models may be utilized to evaluate certain aspects
of joint repair and to optimize speciﬁc environmental vari-
ables24,33,34. The main aim of this study was to directly compare the
in vitro cartilage repair potential of various cell types, as applicable
in surgical cartilage repair procedures, in terms of their interaction
with native articular cartilage and the development of a functional
interface and matrix deposition. In addition, we sought to address
the question of whether maturation of the cell-laden construct
prior to implantation, using pro-chondrogenic growth factor
treatment, inﬂuences subsequent cartilageeimplant interactions.
Our experimental approach was based on an established bovine
“implant in cartilage ring” model24 to assess functional integration
and biochemical/-mechanical properties of cell-laden agarose
constructs in vitro, utilizing differentiated chondrocytes, de-
differentiated chondrocytes after two, ﬁve or eight population
doublings in monolayer-culture, and MSCs. In the ﬁrst study,
freshly prepared constructs of the stated cell types were applied
and cultured inside the native cartilage ring for 28 days in a serum-
free, chemically deﬁned medium (CM). In a second experiment,
corresponding samples were ﬁrst matured in CM supplemented
with 10 ng/mL TGF-b3, designated as CMþ, for 21 days and
implanted afterwards.Materials and methods
Chondrocyte and MSC isolation
MSCs were obtained from femoral and tibial bone marrow of
6e8 month old calves (Fresh Farms Beef, Rutland, VT) as previously
described26. Bone marrow was removed with a spatula and mixed
with an equal volume of Dulbecco's Modiﬁed Eagle's Medium
(DMEM, Gibco BRL) supplemented with antibiotics (50 mg/mL
streptomycin, 50 IU/mL penicillin, Gibco BRL) and 300 U/mL hep-
arin (Sigma). Fat and soft tissue parts were removed by centrifu-
gation (5min, 300g). The resulting cell suspensionwas plated out
onto tissue culture plates (∅ 15 cm) and cell adherencewas allowed
for 48 h. After washing the cultures with phosphate buffered saline
(PBS, Gibco BRL), cells were kept in Expansion Medium (EM; high
glucose DMEM þ 1 antibiotics þ 10% fetal bovine serum (FBS))
until reaching 70e80% conﬂuence. Further culturing was per-
formed at a 1:3 expansion ratio, with cultures of passage 3 utilized
for these studies.
Articular cartilage was harvested from the carpometacarpal
joints of the same group of animals. Cartilage pieces were rinsed
with DMEM containing 2 antibiotics, and kept in a tissue culture
incubator (37C, 5% CO2) overnight. Afterwards, cartilage pieces
were digested sequentially with pronase and collagenase, as
described previously26. The obtained chondrocyte suspension was
ﬁltered (40 mm cell strainer; BD Falcon, Bedford, MA), pelleted
(300 g, 5 min), resuspended in DMEM, and viable cells counted.
These cells were used for the fabrication of agarose implants as
either differentiated cells or sub-cultured inmonolayer at a seeding
density of 1.0  104 cells/cm2 and maintained for two, ﬁve or eight
population doublings, as calculated by microscopic determination
of the cell number, to obtain de-differentiated cell populations.
After 5e6 population doublings chondrocytes reached 70% con-
ﬂuency and cells were passaged in a 1:3 ratio after trypsin
detachment to obtain cells with eight population doublings.
All cell-laden hydrogels and cartilage rings were fabricated by
pooling cells from the same preparation derived from at least six
animals, two preparations were performed in total.
Cell-laden agarose implant preparation, cartilage construct
assembly and culture
Differentiated chondrocytes (Ch0), de-differentiated chon-
drocytes after two (Ch2), ﬁve (Ch5) or eight (Ch8) population
doublings or bone marrow derived MSCs of passage 3 were used to
prepare cell-seeded agarose implants as follows. A suspension of
each of the cell populations (2.0  107 cells/mL) was mixed ho-
mogeneously (1:1) with a sterile agarose solution (42C, 4% w/v in
PBS, type VII, Sigma) to obtain a ﬁnal concentration of
1.0  107 cells/mL. The cell suspension was then cast between two
parallel glass plates and gelatinized for 20 min at room tempera-
ture30, and cylindrical, cell-seeded implants (Ø 4.1 or 6.0 2.25mm
thickness) were cored out using a custom-modiﬁed punch (Ø
4.1 mm) or a dermal punch (Ø 6.0 mm, Miltex, York, PA),
respectively.
To obtain native cartilage rings, full-thickness cartilage cylin-
ders (Ø 8 mm) were harvested from the femoral condyles of
calves. The superﬁcial and deep layer was removed to obtain
parallel surfaces (2.25 mm thickness) and a central “defect”
(4 mm) was cored out. Native cartilage rings were incubated for
24 h (37C, 5% CO2) in a serum-free, chemically deﬁned medium
containing DMEM, 50 mg/mL ascorbate, 0.1 mM dexamethasone,
40 mg/mL L-proline, 100 mg/mL sodium pyruvate, 50 mg/mL ITS-
plus and antibiotics, designated as CM, prior to implantation of
cell-laden agarose constructs.
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each cell type (Ch0/2/5/8 and MSC) were press-ﬁtted into native
cartilage rings immediately after fabrication and cultured as hybrid
construct for 28 days in CM after implantation. Lateral integra-
tion, biochemical composition, biomechanical properties, and his-
tological appearance of the interface region were assessed after 4
weeks. In a second set of experiments, corresponding cell-laden
agarose constructs (Ø 6.0 mm  2.25 mm thickness) of the same
cell preparations as in experiment 1 were ﬁrst pre-treated for 21
days in CM supplemented with 10 ng/mL TGF-b3, designated as
CMþ, prior to implantation. After pre-treatment, the cell-laden
agarose constructs (Ø 6 mm) were rinsed with DMEM, trimmed
to a diameter of 4.1 mm and implanted by press-ﬁtting into freshly
prepared cartilage rings. Further incubation of the hybrid con-
structs and data assessment was performed as described above. All
cultures were maintained in a humidiﬁed atmosphere (37C, 5%
CO2) and medium was changed twice weekly.
Mechanical testing
The equilibrium compressive Young's modulus (Eg) of the
implanted cell-laden agarose constructs was measured using a
custom-made apparatus as previously described26,35. The implants
were removed from the native cartilage ring, their thickness and
diameter measured, placed in PBS and tested in unconﬁned
compression. A tare load of 0.02 Nwas applied and stress relaxation
tests were carried out with a compressive deformation of 1 mm/s to
10%, after which samples were allowed to relax to equilibrium
(1200 s).
Interface strength
The adhesive strength of the interface between the outer native
cartilage ring and the inner engineered tissue was evaluated 28
days after implantation by mechanical push-out test using a
custom-made device mounted on an ELF3200 system (EnduraTec,
Minnetonka, MN). The hybrid construct was placed on a conﬁned
metal ring with a center hole (Ø 5 mm). The implant was then
pushed out with a metal plunger (Ø 3.5 mm), while the applied
force was recorded real time. Failure stress (kPa) was computed
from the applied force that caused total disruption of the interface
and the area of integration (height times circumference)36,37.
Biochemical analyses
The contents of sulfated glycosaminoglycan (sGAG), DNA, and
bulk collagen (ortho-hydroxyproline, OHP) were analyzed to assess
the biochemical composition of the implanted cell-laden con-
structs. All samples were ﬁrst digested for 24 h in papain at 60C.
Aliquots were analyzed for sGAG content using the 1,9-
dimethylmethylene blue dye-binding assay33, for DNA content us-
ing the PicoGreen dsDNA Quantiﬁcation kit (Molecular Probes,
Eugene, OR), and for OHP content (after acid hydrolysis) by reaction
with chloramine T and dimethylaminobenzaldehyde38. Conversion
of OHP content to collagen content was done using a 1:10 ratio of
OHP:collagen39. Each constituent (sGAG, DNA, OHP) was calculated
as the total amount (wet weight) per implant, DNA content was
expressed as relative value compared to the day of implant
fabrication.
Histology and immunochemistry
Hybrid constructs were rinsed with PBS, ﬁxed in 4% buffered
paraformaldehyde, dehydrated in a graded series of ethanol,
parafﬁn-embedded (Tissue Prep, Fisher Scientiﬁc, Hampton, NH),and sectioned at 8 mm thickness. Sections were stained with Alcian
Blue (pH 1.0) to detect sGAG.
For immunohistochemistry, sections were ﬁrst digested with
1 mg/ml hyaluronidase (Sigma) in 10 mM TriseHCl (pH 7.5) for
30 min at 37C. The sections were then incubated overnight at
room temperature with the antibody to collagen type II (Develop-
mental Studies Hybridoma Bank, Iowa City, IA) in Tris-buffered
saline containing 0.1% bovine serum albumin. Immunostaining
was detected histochemically using the streptavidin-peroxidase
Histostain SP Kit for DAB (Zymed Laboratories, San Francisco),
and imaged with a color charge coupled device camera and an
inverted microscope.
Gene expression analysis by real-time reverse transcription-
polymerase chain reaction (RT-PCR)
Total RNA (1 mg) was reverse transcribed using the MultiScribe
reverse transcriptase (Applied Biosystems, Foster City, CA). Real-
time PCR reactions were performed as previously described36.
Gene-speciﬁc primers (forward and reverse) were designed based
on GenBank cDNA sequences (primer sequences available on
request). Speciﬁc transcript levels were normalized by comparison
to that of GAPDH, and expressed as the fold difference (using the
formula 2DDCt) between levels at implant fabrication.
Statistical analyses
All data are reported as the arithmetic mean value (95% conﬁ-
dence interval lower limit, upper limit) of 10e15 samples per
group, measure, and time point. Analysis of variance was per-
formed with cell source (Ch0/2/5/8 or MSC) and pre-treatment
(none or 21 days CMþ) as independent variables and Young's
modulus, failure stress, sGAG/implant, DNA/implant, and bulk
collagen/implant as dependent variables. Statistical signiﬁcance
was determined by Student's t test with signiﬁcance at P < 0.05.
Results
Chondrocyte de-differentiation in monolayer culture
Chondrocytes seeded at a density of 1.0  104 cells/cm2 in cell
culture ﬂask showed plastic adherence after 24 h. De-
differentiation was monitored by Col2 and Col1 gene expression
level and compared to those of freshly isolated chondrocytes (Ch0).
After two population doublings, chondrocytes revealed no signiﬁ-
cant difference in Col2 expression (1.14-fold), whereas the level of
Col1 expression increased 6.06-fold. With increasing number of
population doublings, decrease in Col2 and increase in Col1
expression levels became more pronounced. Finally, after eight
population doublings, Col2 level dropped to 0.12-fold, while a 13.6-
fold increase in Col1 expression was seen, compared to freshly
isolated chondrocytes (data not shown).
Maturation of the cell-laden agarose constructs
TGF-b3 pre-treatment of the different agarose disks in CMþ for
21 days prior to implantation led to increased ECM deposition
within the scaffolds [Fig. 1(A, B)]. Speciﬁcally, differentiated chon-
drocytes exhibited signiﬁcant higher sGAG and bulk collagen
deposition within the agarose disks then any other cell type. As a
function of their population doublings, de-differentiated chon-
drocytes exhibited impaired matrix deposition. Interestingly, MSC-
laden constructs displayed signiﬁcantly higher sGAG and bulk
collagen contents after the pre-culture period in CMþ than chon-
drocytes after two population doublings [Fig. 1(A, B)].
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ECM, which depended on the cell type employed for construct
assembly, major differences in the development of mechanical
properties were also apparent [Fig. 1(C)]. Ch0-laden implants
(Eg¼ 38.76 kPa (46.15, 31.35 kPa)) exhibited the highest increase in
the equilibrium compressive Young's modulus. MSC-laden
(22.35 kPa (28.07, 16.62 kPa)) constructs showed signiﬁcantly
lower mechanical (P ¼ 0.019) properties, but became signiﬁcantly
stiffer (P ¼ 0.004) than Ch5- (4.95 kPa (6.82, 3.08 kPa)) and
(P ¼ 0.003) Ch8- (4.07 kPa (5.68, 2.46 kPa)) laden implants
[Fig. 1(C)]. On the other hand, no signiﬁcant difference (P ¼ 0.295)
in mechanical properties was obvious comparing MSC-laden con-
structs and constructs fabricated with de-differentiated chon-
drocytes after two population doublings (19.86 kPa (24.50,
15.21 kPa); Fig. 1(C)).
DNA content increased slightly in all cell-laden constructs, but
was not signiﬁcant higher compared to the day of fabrication (D1;
Fig. 1(D)).
Biochemical properties of engineered cartilage and the effect of de-
differentiation and pre-treatment
The different cell-laden agarose implants were press-ﬁtted into
native cartilage rings either immediately after fabrication (imma-
ture) or pre-cultured for 21 days in CMþ (mature) and kept as
hybrid constructs in CM for 28 days.
For the immature implants, by day 28 after implantation of
culture in CM, sGAG and bulk collagen contents (mg/implant)
signiﬁcantly increased for all cell types used [Fig. 2(A, C)], compared
to the day of implantation (D1). However, signiﬁcant differences
were obvious among the different cell types utilized. Differentiated
chondrocytes revealed the highest amount of cartilage-speciﬁc
ECM accumulation, compared to de-differentiated chondrocytesFig. 1. Properties of cell-laden agarose constructs after pre-treatment in CMþ for 28 days.
laden constructs were signiﬁcantly increased compared to Day 1 (D1) freshly prepared const
components was found in differentiated chondrocytes (Ch0), while de-differentiated chondr
(MSC) showed signiﬁcantly lower amounts of sGAG and bulk collagen. (C) Equilibrium Young
to the accumulation of ECM after 28 days of CMþ pre-culture. Thus, differentiated chondrocy
higher ECM accumulation in MSC-laden constructs was not correlated with signiﬁcant diff
content compared to Day 1 (D1). All cell-laden agarose disks showed a slight but insigniﬁca
Experiments represent culture replicates originating from pooled cells. Values are mean w(Ch2/5/8) and MSCs [Fig. 2(A, C)], with MSC-laden constructs
exhibiting no signiﬁcant difference to those seeded with Ch2.
For the mature implants, cultured in CM for 28 days as hybrid
constructs, analysis of the accumulated cartilage-speciﬁc ECM
molecules revealed signiﬁcant differences among the cell types
used [Fig. 2(B, D)]. Again, differentiated chondrocytes produced the
highest amounts of sGAG and bulk collagen. Interestingly, even
after removal of TGF-b3 supplementation, MSCs showed prolonged
ECM production and their sGAG and bulk collagen contents were
signiﬁcantly higher than those of Ch2, Ch5, or Ch8 implants
[Fig. 2(B, D)].
Mechanical properties of engineered cartilage and the effect of de-
differentiation and pre-treatment
In the immature implants, the mechanical properties after 28
days in CM culture medium as hybrid constructs closely corre-
lated with the amount of accumulated ECM components. Thus, the
equilibrium compressive Youngs's modulus (EY) of Ch0-laden im-
plants exhibited the highest increase (18.4 kPa (10.06, 16.74 kPa)),
2.5-fold stiffer than those of Ch2- (7.87 kPa (8.79, 6.94 kPa)) and
MSC- (7.48 kPa (8.55, 6.4 kPa)) laden implants [Fig. 3(A)]. Ch5-
(2.78 kPa (3.51, 2.05 kPa)) and Ch8- (1.96 kPa (2.61, 1.32 kPa)) laden
agarose implants showed no signiﬁcant increase (P ¼ 0.151 and
P¼ 0.363 respectively) in mechanical stability above the baseline of
freshly prepared disks (2.15 kPa (2.72, 1.57 kPa)) after implantation
and culture.
For TGF-b3 pre-treated mature implants, sustained matrix
production during subsequent culture as hybrid constructs in
CM medium led to further increase of mechanical properties
[Fig. 3(B)]. The highest equilibrium Young's modulus was detected
in Ch0-laden implants (60.84 kPa (68.55, 53.12 kPa)). Interest-
ingly, even after removal of TGF-b3 during subsequent culture,(A) sGAG content (mg/implant) and (B) bulk collagen content (mg/implant) of all cell-
ructs in a manner dependent on the cell type used. The highest accumulation of matrix
ocytes after two (Ch2), ﬁve (Ch5) and eight (Ch8) population doublings, as well as MSCs
's modulus (Eg; kPa). The mechanical property of the constructs appeared to be related
te-laden agarose disks showed the highest compressive Young's modulus. However, the
erence in mechanical properties compared to Ch2-laden constructs. (D) Relative DNA
nt increase in cell number after the 28-day culture period. *p ¼ displays P-value vs D1.
ith 95% conﬁdence interval upper limit and lower limit (n ¼ 10).
Fig. 2. sGAG and collagen contents of cell-laden agarose constructs after 28 days of culture in CM as hybrid constructs. (A, B) sGAG content (mg/implant) and (C, D) bulk collagen
content (mg/implant). (A, C) Immature constructs and (B, D) mature constructs. Chondrocyte expansion culture prior to construct fabrication led to a signiﬁcant depletion in matrix
accumulation for both immature and pre-treated implants, depending on the number of population doublings. Maturation of MSC-laden agarose constructs resulted in sustained
matrix deposition that prolonged even after implantation and removal of TGF-b3. For each data bar, the amounts of (B) sGAG and (C) bulk collagen deposited during the 21-day pre-
culture in CMþ is indicated in gray, and the amount synthesized during hybrid culture part in white. *p ¼ displays P-value vs different cell type. Experiments represent culture
replicates originating from pooled cells. Values are mean with 95% conﬁdence interval upper limit and lower limit (n ¼ 10e15).
L. Rackwitz et al. / Osteoarthritis and Cartilage 22 (2014) 1148e11571152MSC-laden implants (39.38 kPa (44.56, 34.19 kPa)) exhibited
signiﬁcantly higher (P ¼ 0.027, P < 0.001 and P < 0.001 respec-
tively) mechanical properties compared to those fabricated with
Ch2 (29.46 kPa (33.09, 25.84 kPa)), Ch5 (6.79 kPa (7.63, 5.95 kPa)),
or Ch8 (5.09 kPa (5.7, 4.48 kPa); Fig. 2(B)). In comparison, the
surrounding native bovine cartilage exhibited a Young's modulus
of 500e800 kPa.Fig. 3. Mechanical properties of (A) immature and (B) mature, TGF-b3 pre-treated cell-laden
matrix synthesis described previously for de-differentiated chondrocytes after two (Ch2),
mechanical properties compared to differentiated chondrocytes (Ch0) in the (B) mature as
MSC-laden constructs (MSC) exhibited superior mechanical properties only after pre-treat
within the corresponding group. *p ¼ displays P-value vs different cell type. Experiments
conﬁdence interval upper limit and lower limit (n ¼ 10e15).Adhesive strength of the interface and the effect of de-differentiation
and pre-treatment
Push-out tests after 28 days of culture as hybrid construct
revealed the development of an adhesive interface between all
implants and the native cartilage, but major differences were
detected for both the immature and pre-treated groups [Fig. 4(A,constructs 28 days after implantation into the native cartilage rings. The impairment in
ﬁve (Ch5) and eight (Ch8) population doublings was reﬂected by signiﬁcantly lower
well as in the (A) immature group. In comparison to de-differentiated chondrocytes,
ment with CMþ. Differentiated chondrocytes (Ch0) outperformed all other cell types
represent culture replicates originating from pooled cells. Values are mean with 95%
L. Rackwitz et al. / Osteoarthritis and Cartilage 22 (2014) 1148e1157 1153B)]. In general, implants prepared using differentiated chon-
drocytes exhibited the strongest integration into the native carti-
lage rings in both groups, irrespective of TGF-b3 pre-treatment.
Speciﬁcally, mature Ch0 implants showed signiﬁcantly higher
(P < 0.001) interface strength than immature Ch0 implants
(82.67 kPa (90.32, 75.03 kPa) vs 25.5 kPa (28.81, 22.19 kPa)). In the
immature group, the failure stress of Ch2 implants (12.9 kPa (14.97,
10.83 kPa)) was similar (P ¼ 0.16) to of MSC implants (11.01 kPa
(13.02, 9.01 kPa)). However, Ch5- (5.45 kPa (7.23, 3.67 kPa)) and
Ch8-implants (4.94 kPa (6.02, 3.86 kPa)) integrated signiﬁcantly
less into the native cartilage [Fig. 4(A)]. Mature implants fabricated
with Ch0, Ch2, Ch5 or MSCs showed signiﬁcantly higher interface
strength (82.67 kPa (90.32, 75.03 kPa, P < 0.001); 36.9 kPa (41.64,
32.15 kPa, P < 0.001); 12.04 kPa (15.99, 8.1 kPa, P ¼ 0.029); and
51.88 kPa (58.3, 45.46 kPa, P < 0.001) respectively) compared to the
corresponding immature agarose implants after 28 days in hybrid
culture [Fig. 4(A, B)]. Notably, the integration of pre-treated MSC-
laden implants was signiﬁcantly stronger compared to that
measured for de-differentiated chondrocytes after two, ﬁve or eight
population doublings (P ¼ 0.016, P < 0.001 and P < 0.001 respec-
tively) in the mature implant group. In contrast, for Ch8 implants,
TGF-b3 pre-treatment failed to increase interface strength signiﬁ-
cantly (P¼ 0.064) 28 days after implantation (mature Ch8 implants,
8.56 kPa (11.62, 5.48 kPa); immature Ch8 implants, 4.94 kPa (6.02,
3.86 kPa)).
Immunohistological analysis of the interface
The histological features of the interface region were consistent
with ECM biochemical properties (Fig. 5). Collagen type II and
alcian blue positive staining decreased with increased population
doublings of chondrocytes. On the other hand, while comparable
positive collagen type II staining was seen in TGF-b3 pre-treated
Ch2 and MSC implants 28 days after implantation, alcian blue
staining was stronger in the latter. Ch5 implants, even after TGF-b3
pre-treatment, exhibited very low staining intensity for cartilage-
speciﬁc ECM and less visible cells. In addition, mature Ch5 implantsFig. 4. Interface strength (kPa) developed between the cell-laden implant and the opposing
For chondrocytes, in addition to the negatively affected gross matrix synthesis and lower mec
number of population doublings prior to construct fabrication. (A) Mature cell-laden constru
or ﬁve (Ch5) population doublings, and MSCs (MSC) exhibited signiﬁcantly higher interface s
different cell type; **p ¼ displays P-value vs corresponding cell-type of the immature group.
with 95% conﬁdence interval upper limit and lower limit (n ¼ 10e15).revealed a more pronounced alcian blue staining in the inter-
territorial region compared to the intensive pericellular staining
of implants with Ch0/2 or MSCs (Fig. 5).
Discussion
Our data clearly demonstrate that monolayer expansion of
chondrocytes severely impairs their maturation and the develop-
ment of a sufﬁcient interface between native articular cartilage and
the implant. Reduced biosynthetic activity of the chondrocytes, and
inferior mechanical properties, and tissue integration were evident
after two population doublings. Our results are supported by the
work of Darling and Athanasiou40, showing rapid phenotypic
changes in expanded goat articular chondrocytes. These changes in
chondrocyte speciﬁc gene expression are not reversible, even in
three-dimensional alginate culture40. In this assay system, the
presence of living native cartilage after construct implantation
provides additional environmental factors that inﬂuence the inte-
gration/maturation of the tissue-engineered implants. For example,
freshly injured cartilage has been shown to secrete a number of
growth factors, namely members of the TGF-b family41, that are
known for their pro-chondrogenic inﬂuence on chondrocytes and
MSCs20,27,42. However, immature MSC-laden hydrogel constructs
cultured in CM after implantation exhibited only sporadic chon-
drogenic differentiation, as revealed by histological analysis, and
their biosynthetic activity and the consequential mechanical
properties and integration were comparable to chondrocytes after
two population doublings, although signiﬁcantly higher than that
of chondrocytes that were further de-differentiated by additional
population doubling.
The successful long-term restoration of isolated cartilage defects
using matrix-based autologous chondrocyte implantation is
dependent on the development of neo-cartilage with biochemical
composition and mechanical properties comparable to those of
native articular cartilage. Effective integration of the developing
neo-tissue into the surrounding native cartilage is needed to opti-
mize physiological load distribution within the joint and avoidnative cartilage for (A) immature and (B) mature constructs 28 days after implantation.
hanical properties, interface strength was also compromised in a manner related to the
cts of differentiated chondrocytes (Ch0), de-differentiated chondrocytes after two (Ch2)
trengths compared to the corresponding (A) immature implant. *p ¼ displays P-value vs
Experiments represent culture replicates originating from pooled cells. Values are mean
Fig. 5. Histological cartilage matrix deposition at the interface zone obtained 28 days after the implantation of immature and mature cell-laden agarose hydrogels. In each panel,
cell-laden construct is on top and native cartilage is in the bottom. Alcian blue staining and collagen type II immunostaining both showed decreased cartilage matrix components
with increased population doublings of chondrocytes for both the immature and the matured agarose disks. Comparable, positive collagen type II staining was seen in TGF-b3 pre-
treated Ch2 and MSC implants, while alcian blue staining seemed slightly stronger in MSC-laden cartilage analogs. Bar ¼ 50 mm.
L. Rackwitz et al. / Osteoarthritis and Cartilage 22 (2014) 1148e11571154further destruction of the cartilage2,25,43,44. In vitro maturation of
tissue-engineered cartilage analogs prior to implantation has been
reported to result in improved defect ﬁlling and a higher amount of
hyaline cartilage in a canine cartilage defect model31. In addition,
in vitro experimental data from studying the integration of
opposing native cartilage pieces showed stronger fusion when
cartilage pieces were of comparable developmental stage45, with
the integration processes dependent on cellular activity and
collagen deposition45e48.
Members of the TGF-b superfamily have been shown to induce
chondrogenic differentiation in MSCs6,20,26,27,42 and to promote a
chondrogenic phenotype26. Our data showed that constructs of
freshly isolated chondrocytes exhibited sustained ECM deposition
after pre-culture in TGF-b3 containing medium. In comparison,
matrix deposition by de-differentiated chondrocytes is signiﬁcantly
diminished, as a function of the number of prior population dou-
blings. Remarkably, after pre-treatment with TGF-b3, the MSCs
seeded in agarose hydrogel showed signiﬁcantly higher matrix
productionwith superior mechanical properties compared to those
seeded with culture expanded chondrocytes. In addition, cell-laden
constructs of Ch0, Ch2 and MSCs showed further signiﬁcant in-
crease of cartilage-speciﬁc ECM content and mechanical properties
after implantation and maintenance as hybrid culture in CM,
accompanied by improved integration when compared to the cor-
responding immature implants culture under the same conditions.
These results expose the deﬁciency in chondrogenic cell
response to TGF-b3-mediated cartilage maturation caused by
increased population doubling of de-differentiated chondrocytes,
resulting in subsequent limited cartilage repair in vitro. This is likely
to be the underlying cause of the weak interface strength observed
when there was disparity in developmental stage between the
implant and the opposing native cartilage, with accompanyingreduction in collagen deposition23,24,34,45,47. Nevertheless, it is
noteworthy that differentiated chondrocytes outperformed all cell
types tested here in terms of cartilage repair capacity, and should
thus be the cell type of choice. However, other factors need to be
considered as well, as matrix deposition and mechanical properties
of the engineered tissue constructs depend not only on the cell type
utilized, but also on cell viability, cell-to-volume ratio, culture
conditions, and donor age and species11,20,24,27,28,35,37. To obtain a
sufﬁcient number of chondrocytes, monolayer expansion of chon-
drocytes is a routinely used approach in the treatment of cartilage
defects utilizing autologous chondrocyte implantation. Our in vitro
ﬁndings thus strongly suggest that the current limitations of
autologous chondrocyte implantation and related approaches to
cartilage repair is a consequence of impairment in cellular activity
and responsiveness to anabolic factors as a result of culture
expansion of the cells49. Recent publications have reported strate-
gies to avoid or minimize the impact of the de-differentiation
process on chondrocyte phenotype during culture expansion, by
varying the initial seeding density50, medium composition51,52 and
culture conditions53e55.
Remarkably, pre-differentiated MSC-laden collagen hydrogels
have been demonstrated to result in superior repair tissue
compared to hydrogels seeded with either un-differentiated MSCs
or chondrocytes in an ovine osteochondral defect model after 6 and
12 months30,32. In addition, initial clinical trials applying MSC-
laden collagen type I-hydrogels into isolated cartilage defects in
humans have shown promising results56,57. In contrast, hypertro-
phic differentiation and ectopic bone formation after in vivo im-
plantation of MSCs have been reported in animal experiments58,59.
However, we observed, without pre-treatment in CMþ, only spo-
radic chondrogenic differentiation and inferior matrix accumula-
tion in MSC-laden implants, resulting in weak integration between
L. Rackwitz et al. / Osteoarthritis and Cartilage 22 (2014) 1148e1157 1155the native cartilage and the construct. On the other hand, TGF-b3
pre-treatment of MSC-laden hydrogels resulted in an increased
deposition of ECM components and cartilage integration after im-
plantation, superior to de-differentiated chondrocytes. Interest-
ingly, while signiﬁcantly higher amount of collagen deposition in
MSC-laden constructs was seen after implantation compared to
those derived from de-differentiated chondrocytes (Ch5 and Ch8),
their total collagen content as well as immunohistochemically
detected collagen type II matrixwere similar to those of Ch2 but not
differentiated chondrocytes. These ﬁndings suggest incomplete
chondrogenic differentiation and maturation of the MSCs in the
engineered construct, and the need for further investigation to
optimize the guided chondrogenic program of MSCs for improved
cartilage-speciﬁc matrix deposition and integration26.
Conclusion
Our ﬁndings clearly indicate that freshly isolated articular
chondrocytes exhibit the highest quality of in vitro cartilage repair,
such that mature implants derived from these cells show acceler-
ated integration of the cell-laden implants into the opposing native
articular cartilage. Culture-expanded, de-differentiated chon-
drocytes are compromised in their cartilage repair capacity with
increasing number of population doublings. In addition, de-
differentiated chondrocytes exhibit inferior cell response to chon-
drogenic anabolic factors, such as TGF-b3, accompanied by inferior
mechanical properties and integration. In comparison, MSCs pre-
treated with TGF-b3 CMþ conditions show favorable chondro-
genic differentiation and superior accumulation of cartilage-spe-
ciﬁc ECM after implantation, supporting their applicability in
matrix-based cartilage repair strategies.
In conclusion, our study demonstrate the utility of an in vitro
assay system that has functionally predictive read-outs in terms of
tissue integration for the development and optimization of tissue
engineering approaches to cartilage repair.
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